DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,775.00
+105.00 (2.86%)
Nov 20, 2025, 3:30 PM KST
DK Life Science Revenue
DK Life Science had revenue of 34.89B KRW in the quarter ending June 30, 2025, with 3.94% growth. This brings the company's revenue in the last twelve months to 134.14B. In the year 2024, DK Life Science had annual revenue of 131.82B with 9.70% growth.
Revenue (ttm)
134.14B
Revenue Growth
+9.70%
P/S Ratio
0.89
Revenue / Employee
1.31B
Employees
100
Market Cap
117.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.82B | 11.65B | 9.70% |
| Dec 31, 2023 | 120.16B | 12.93B | 12.05% |
| Dec 31, 2022 | 107.23B | 4.57B | 4.45% |
| Dec 31, 2021 | 102.67B | -6.91B | -6.31% |
| Dec 31, 2020 | 109.58B | 10.97B | 11.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.50T |
| SK Biopharmaceuticals | 620.28B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |
| LigaChem Biosciences | 148.28B |